P2X3 receptor antagonist (Gwangju Institute of Science & Technology/Chonnam National University/Daegu-Gyeongbuk Medical Innovation Foundation/Korea Institute of Science and Technology)

N/A

报告时间: 2025/03/20 20:00:06

NME

基本信息

药物名称P2X3 receptor antagonist (Gwangju Institute of Science & Technology/Chonnam National University/Daegu-Gyeongbuk Medical Innovation Foundation/Korea Institute of Science and Technology)

药物别称P2X3 receptor antagonists (Gwangju Inst Sci & Tech/Chonnam National Univ/Daegu-Gyeongbuk Medical Innovation Foundation/KIST)

药物类型化学药 > 有机杂环药物

作用机制嘌呤P2X3受体拮抗剂

靶点嘌呤P2X3受体

治疗领域 / 适应症神经痛

全球批准适应症N/A

中国批准适应症N/A

首批国家/区域N/A

首批日期N/A

国家/区域韩国

是否复方否

全球最高研发状态无进展 (临床前)

中国最高研发状态N/A

原研公司Gwangju Institute of Science and Technology

注册分类N/A

研发信息

活跃公司N/A

非活跃公司Chonnam National University Daegu-Gyeongbuk Medical Innovation Foundation Korea Institute Of Science And Technology +[4]

活跃适应症N/A

非活跃适应症神经痛

其他信息

ATC代码N/A